alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                                                                    Exhibit 10.1

[WINDOWS HARDWARE QUALITY LABS LETTERHEAD]

OCTOBER 11, 2001

Paul Vetri
Litronic, Inc.
2030 Main Street #1250
Irvine, CA 92614


Paul Vetri,

Due to certain Microsoft Windows Logo Program requirements that the following
product does not fully meet at the time of testing, the Logo is awarded a
contingency basis for Windows 98, Windows ME and Windows 2000.

Product:  ARGUS 2500 (MID44316)

Please send a copy of this letter with the submission paperwork for this
product line when you make your submission. When submitted for Logo
qualification, the product must pass all Windows Hardware Quality Labs testing
not related to the following issues.

Issue:

The ARGUS 2500 PCI CardBus/PCMCIA controller needs additional software to
enable the support PCMCIA devices for ISA IRQ Routing support. For Windows
2000, Service Pack 3 will have the based support for ISA IRQ Routing. Windows
2000 portion of the contingency will be expired, after 90 days upon the
availability of Service Pack 3.

If Litronic, Inc. agrees with the foregoing terms and conditions, please sign
where indicated below. The signed original must also be sent to:

Windows Hardware Quality Labs
One Microsoft Way
Redmond, WA 98052-6399

When the product is ready for retesting, please send the hardware to:

Windows Hardware Quality Labs
One Microsoft Way
Redmond, WA 98052-6399


<PAGE>
MICROSOFT CORPORATION                   LITRONIC, INC.


Gordon Lacey                            Robert Gray
---------------------------------       -------------------------------------
Name (print)                            Name (print)


/s/ Gordon Lacey                        /s/ Robert Gray
---------------------------------       -------------------------------------
Name (signature)                        Name (signature)


WHQL Group Manager                      V.P., R&D
---------------------------------       -------------------------------------
Title                                   Title


Oct. 26, 2001                           10/17/01
---------------------------------       -------------------------------------
Date                                    Date


GORDAN LACEY
GROUP MANAGER, WHQL
WINDOWS DIVISION
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr., Chief Justice

Michael F. Cavanagh

Marilyn Kelly

Stephen J. Markman

Diane M. Hathaway

Mary Beth Kelly

Brian K. Zahra, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 _________________________________________

 Clerk

November 7, 2012

p1031

Order 

November 7, 2012

145260

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee,

v SC: 145260

COA: 303385

Jackson CC: 10-005672-FH

DAVID LEE SWANIGAN,

Defendant-Appellant.

_________________________________________/

On order of the Court, the application for leave to appeal the May 15, 2012 

judgment of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court.
# L_2005031EN.01007301.xml

| 4.2.2005 | EN | Official Journal of the European Union | L 31/73 |
| --- | --- | --- | --- |

4.2.2005

EN

Official Journal of the European Union

L 31/73

---

COUNCIL JOINT ACTION 2005/99/CFSP

of 2 February 2005

extending the mandate of the Special Representative of the European Union for the Middle East peace process

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on European Union, and in particular Articles 14, 18(5) and 23(2) thereof,

Whereas:

| (1) | On 8 December 2003 the Council adopted Joint Action 2003/873/CFSP (1) extending and amending the mandate of the Special Representative of the European Union for the Middle East peace process. |
| --- | --- |

(1)

On 8 December 2003 the Council adopted Joint Action 2003/873/CFSP (1) extending and amending the mandate of the Special Representative of the European Union for the Middle East peace process.

| (2) | On 28 June 2004 the Council adopted Joint Action 2004/534/CFSP (2), extending until 28 February 2005 Joint Action 2003/873/CFSP. |
| --- | --- |

(2)

On 28 June 2004 the Council adopted Joint Action 2004/534/CFSP (2), extending until 28 February 2005 Joint Action 2003/873/CFSP.

| (3) | On the basis of a review of Joint Action 2003/873/CFSP, as amended by Joint Action 2004/534/CFSP, the mandate of the Special Representative should be extended for a further six months, |
| --- | --- |

(3)

On the basis of a review of Joint Action 2003/873/CFSP, as amended by Joint Action 2004/534/CFSP, the mandate of the Special Representative should be extended for a further six months,

HAS ADOPTED THIS JOINT ACTION:

Article 1

The mandate of Mr Marc OTTE as the European Union Special Representative (EUSR) for the Middle East peace process, as set out in Joint Action 2003/873/CFSP and as amended by Joint Action 2004/534/CFSP, is hereby extended until 31 August 2005.

Article 2

Article 5(1) of Joint Action 2003/873/CFSP is hereby replaced by the following:

‘1.   The financial reference amount intended to cover the expenditure related to the mandate of the EUSR shall be EUR 560 000’.

Article 3

This Joint Action shall enter into force on the day of its adoption.

Article 4

This Joint Action shall be published in the Official Journal of the European Union.

Done at Brussels, 2 February 2005.

For the Council

The President

J. ASSELBORN

---

(1)  
  OJ L 326, 13.12.2003, p. 46.

1

(2)  
  OJ L 234, 3.7.2004, p. 18.

2

---
II 

118TH CONGRESS 

1ST SESSION S. 36 

To review domestic biopharmaceutical manufacturing capabilities in order 

to improve public health and medical preparedness and response capabilities and domestic biopharmaceutical manufacturing capabilities. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 24 (legislative day, JANUARY 3), 2023 

Mr. RUBIO (for himself and Mr. COONS) introduced the following bill; which 

was read twice and referred to the Committee on Health, Education, 

Labor, and Pensions 

A BILL 

To review domestic biopharmaceutical manufacturing capabilities in order to improve public health and medical 

preparedness and response capabilities and domestic biopharmaceutical manufacturing capabilities. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Agility in Manufac5 turing Preparedness Act of 2023’’. 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•S 36 IS

1 SEC. 2. REVIEW OF DOMESTIC BIOPHARMACEUTICAL MAN2 UFACTURING CAPABILITIES. 

3 (a) IN GENERAL.—The Secretary of Health and 

4 Human Services (referred to in this section as the ‘‘Sec5 retary’’), in cooperation with the Director of the Bio6 medical Advanced Research and Development Authority, 

7 shall seek to enter into an agreement with the National 

8 Institute for Innovation in Manufacturing Biopharma9 ceuticals to perform the services described in subsection 

10 (b). 

11 (b) REVIEW AND RECOMMENDATIONS.—Under an 

12 agreement described in subsection (a) between the Sec13 retary, the Director of the Biomedical Advanced Research 

14 and Development Authority, and the National Institute for 

15 Innovation in Manufacturing Biopharmaceuticals, the Na16 tional Institute for Innovation in Manufacturing Bio17 pharmaceuticals shall— 

18 (1) review current domestic biopharmaceutical 

19 manufacturing capacity at the Department of 

20 Health and Human Services and such department’s 

21 adaptability to various threats; 

22 (2) draft recommendations for developing, dem23 onstrating, deploying, and advancing new domestic 

24 biopharmaceutical manufacturing technologies that 

25 address gaps identified under paragraph (1) and 

26 align Federal technologies with technologies availVerDate Sep 11 2014 03:00 Jan 27, 2023 Jkt 039200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S36.IS S36

pbinns on DSKJLVW7X2PROD with $$_JOB
3 

•S 36 IS

1 able to the private sector, including through the new 

2 BioMAP initiative of the Biomedical Advanced Re3 search and Development Authority; and 

4 (3) identify other opportunities and priorities to 

5 improve the United States public health and medical 

6 preparedness and response capabilities and domestic 

7 biopharmaceutical manufacturing capabilities. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB
|  |  | [if !vml]>[endif]>

You have  reached the Federal Depository Library Program Electronic Collection  (FDLP/EC) Archive. This archive assures ongoing access to publications in the  FDLP/EC. Access to publications in the archive is available through GPO's  suite of cataloging and locator services, including the Catalog of U.S.  Government Publications (CGP).
Title: Environmental    impact statement for the proposed flourine extraction    process and depleted uranium deconversion plant    in Lea County, New Mexico [electronic resource] : draft report    for comment
 
SuDocs Number:[if !vml]>[endif]>Y 3.N 88:10/2113
Item    Number:1051-H-02    (online)
GPO    System Number: 000868767
 
 
 
Volume 1
 
Volume 2
 
A service of the Superintendent of Documents,  U.S. Government Printing Office..

 

Last updated:  June, 8, 2020  Page Name:  http://permanent.access.gpo.gov/
perm |
|--|--|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
**Exhibit 23****Consent of Independent Registered Public Accounting Firm**We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos.333-112215, 33-74492, 333-3398, 333-71627, 333-36222, 333-43274, 333-54652, 333-81926, 333-124588and 333-129742) of Actel Corporation of our reports datedMarch 14, 2008, with respect to theconsolidated financial statements and schedule of Actel Corporation and the effectiveness ofinternal control over financial reporting of Actel Corporation, included in this Annual Report(Form 10-K) for the year ended January 6, 2008./s/ Ernst & Young LLPSan Jose, California
**Exhibit (n)(1)**

**DWS VALUE EQUITY TRUST**

**AMENDED AND RESTATED**

**MULTI-DISTRIBUTION SYSTEM PLAN**

 

WHEREAS, DWS Value Equity Trust adopting this Amended and Restated Multi-Distribution System Plan (the “Fund,” and each underlying portfolio of the Fund, a “Series”) is an open-end investment management company registered under the Investment Company Act of 1940, as amended (the “1940 Act”);

 

WHEREAS, Deutsche Investment Management Americas Inc. (“DIMA”) serves as investment adviser and DWS Investments Distributors, Inc. (“DIDI”) serves as principal underwriter for the Fund;

 

WHEREAS, the Fund has established an Amended and Restated Multi-Distribution System enabling each Series, as more fully reflected in its prospectuses, to offer investors the option of purchasing shares of the Series with one or more of the following classes of shares: (a) with a front-end sales load (which may vary among Series) and Rule 12b-1 Plan providing for a service fee (“Class A shares”); (b) without a front-end sales load, but subject to a contingent deferred sales charge (“CDSC”) (which may vary among Series) and a Rule 12b-1 plan providing for a distribution fee and a service fee (“Class B shares”); (c) without a front-end sales load, but subject to a CDSC (which may vary among Series) and a Rule 12b-1 Plan providing for a distribution fee and a service fee (“Class C shares”); (d) solely to certain investors, without a front-end salesload, a CDSC, a distribution fee or a service fee (“Class S shares”); and (e) solely to eligible institutions and other eligible investors, without a front-end sales load, a CDSC, or a Rule 12b-1 plan providing for a distribution fee or service fee, but for certain funds with a service plan providing for a service fee (“Institutional Class shares”);****

 

WHEREAS, a Fund or a Series may offer or issue some or all of the classes listed above; 

 

WHEREAS, Rule 18f-3 under the 1940 Act permits open-end management investment companies to issue multiple classes of voting stock representing interests in the same portfolio notwithstanding Sections 18(f)(1) and 18(i) under the 1940 Act if, among other things, such investment companies adopt a written plan setting forth the separate arrangement and expense allocation of each class and any related conversion features or exchange privileges;

 

NOW, THEREFORE, the Fund, wishing to issue multiple classes of shares in accordance with Rule 18f-3 under the 1940 Act, hereby adopts this Amended and Restated Multi-Distribution System Plan, as follows, on behalf of the Series:

 

1.        Each class of shares will represent interests in the same portfolio of investments of the Series, and be identical in all respects to each other class, except as set forth below.  The only differences among the various classes of shares of the Series will relate solely to: (a) different distribution fee payments or service fee payments associated with any Rule 12b-1 Plan for a particular class of shares and any other costs relating to implementing or amending such Rule 12b-1 Plan (including obtaining shareholder approval of such Rule 12b-1 Plan or any 

 

----
Exhibit 77D - DWS Large Company Growth
Fund (a series of DWS Investment Trust)

Effective February 20, 2009, for DWS Large
Company Growth Fund, a series of DWS Investment
Trust, the Fund's investment strategy was modified
as follows:

The portfolio managers may favor different types of
securities from different industries and companies at
different times.

In choosing stocks, the portfolio managers begin by
utilizing a proprietary quantitative model to rank
stocks based on a number of factors including
valuation and profitability. The portfolio managers
also apply fundamental techniques to identify
companies that display above-average earnings
growth compared to other companies and that have
strong product lines, effective management and
leadership positions within core markets. The factors
considered and models used by the portfolio
managers may change over time.





E:\Electronic Working Files\NSAR\2009\1-31-09\DWS Investment
Trust (semi)\03-Exhibits\Exhibit 77D.doc
Confirmation on criteria for EPA to deem GHG permit application complete ?

Flajole, Andy to: Andrew Parks 08/10/2012 11:57 AM

Cc: "Foster, Stacy"

History: This message has been replied to and forwarded.

Hi Andrew,

Per my voicemail a few minutes ago, FPL is seeking confirmation on the criteria that will be used to

deem FPL’s GHG air permit application “complete”. When last we spoke you stated that the EPA will

deem our GHG application “complete” via written correspondence upon a conclusion made by both EPA

(you) and NOAA (Audra) that the Biological Assessment contains all necessary information for the

agencies to make an effects determination on endangered species within the project action area. My

management has requested written verification of this as it is so critical to our Port Everglades

modernization project schedule.

Please call me if you want to discuss. I appreciate an email reply at your earliest convenience.

Thank You,



# Andy Flajole

Environmental Services

(561) 691

‐ 2766
Pickering
J.

plea agreement, this assertion has no support in the record. Accordingly, we ORDER the judgment of the district court AFFIRMED. 2

Saitta cc. Hon. Steve L. Dobrescu, District Judge Rodney Halbower Attorney General/Carson City White Pine County District Attorney Attorney GeneraVEly White Pine County Clerk

2 In light of this disposition, we deny as moot appellant's motions for appointment of counsel and to continue litigation. We have reviewed all documents that appellant has submitted in proper person to the clerk of this court in this matter, and we conclude that no relief based upon those submissions is warranted. To the extent that appellant has attempted to present claims or facts in those submissions which were not previously presented in the proceedings below, we have declined to consider them in the first instance.

SUPREME COURT OF NEVADA 2 (0) 1947A
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of Cygne Designs, Inc. (the  Company) on Form 10-K/A for the year ending January 31, 2008 as filed
with the Securities and Exchange Commission on the date hereof (the Report), I, Samuel J. Furrow, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes
-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of
1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.



By:

/s/ Jay FurrowJay FurrowPresident and Chief Executive OfficerMay 23, 2008
# L_2005208EN.01001701.xml

| 11.8.2005 | EN | Official Journal of the European Union | L 208/17 |
| --- | --- | --- | --- |

11.8.2005

EN

Official Journal of the European Union

L 208/17

---

COMMISSION REGULATION (EC) No 1311/2005

of 10 August 2005

on the issue of import licences for high-quality fresh, chilled or frozen beef and veal

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EC) No 1254/1999 of 17 May 1999 on the common organisation of the market in beef and veal (1),

Having regard to Commission Regulation (EC) No 936/97 of 27 May 1997 opening and providing for the administration of tariff quotas for high-quality fresh, chilled and frozen beef and for frozen buffalo meat (2),

Whereas:

| (1) | Regulation (EC) No 936/97 provides in Articles 4 and 5 the conditions for applications and for the issue of import licences for meat referred to in Article 2(f). |
| --- | --- |

(1)

Regulation (EC) No 936/97 provides in Articles 4 and 5 the conditions for applications and for the issue of import licences for meat referred to in Article 2(f).

| (2) | Article 2(f) of Regulation (EC) No 936/97 fixes the amount of high-quality fresh, chilled or frozen beef and veal meeting the definition laid down therein which may be imported on special terms for the period 1 July 2005 to 30 June 2006 at 11 500 t. |
| --- | --- |

(2)

Article 2(f) of Regulation (EC) No 936/97 fixes the amount of high-quality fresh, chilled or frozen beef and veal meeting the definition laid down therein which may be imported on special terms for the period 1 July 2005 to 30 June 2006 at 11 500 t.

| (3) | It should be recalled that licences issued pursuant to this Regulation will, throughout the period of validity, be open for use only in so far as provisions on health protection in force permit, |
| --- | --- |

(3)

It should be recalled that licences issued pursuant to this Regulation will, throughout the period of validity, be open for use only in so far as provisions on health protection in force permit,

HAS ADOPTED THIS REGULATION:

Article 1

1.   All applications for import licences from 1 to 5 August 2005 for high-quality fresh, chilled or frozen beef and veal as referred to in Article 2(f) of Regulation (EC) No 936/97 shall be granted in full.

2.   Applications for licences may be submitted, in accordance with Article 5 of Regulation (EC) No 936/97, during the first five days of September 2005 for 2 648,030 t.

Article 2

This Regulation shall enter into force on 11 August 2005.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 10 August 2005.

For the Commission

J. M. SILVA RODRÍGUEZ

Director-General for Agriculture and Rural Development

---

(1)  
  OJ L 160, 26.6.1999, p. 21. Regulation as last amended by Regulation (EC) No 1782/2003 (OJ L 270, 21.10.2003, p. 1).

1

(2)  
  OJ L 137, 28.5.1997, p. 10. Regulation as last amended by Regulation (EC) No 1118/2004 (OJ L 217, 17.6.2004, p. 10).

2

---
No. 9604.

#### Pavey *v.*Pavey.

(Decided October 30, 1906.)

Error to Circuit Court of Fayette County.

, *Messrs. Gardner & Chaffin,*for plaintiff in error.

*Mr. John Logan,*for defendant in error.

Judgment affirmed.

Shauck,- C. J., Price, Crew, Summers, Spear and Davis, JJ., concur.
254 La. 636

#### CITY OF NEW ORLEANS v. Ray J. ROGER

No. 50069.

Supreme Court of Louisiana.

Aug. 22, 1969.

In re: Ray J. Roger applying for writs of review, prohibition, mandamus and cer-tiorari.

Application denied. There is no error of law in the judgment complained of.
Exhibit 23.1




Consent of Independent Accountants



We consent to the incorporation by reference in the registration statements of
MRS Technology, Inc. on Form S-8 (File Nos.  33-79476, 33-85148, 33-85262) of
our report dated May 5, 1998 on our audits of the consolidated financial
statements of MRS Technology, Inc. as of March 31, 1998 and 1997, and for each
of the three years in the period ended March 31, 1998, which report is
included in this Annual Report on Form 10-K.


/s/ Coopers & Lybrand L.L.P.
Boston, Massachusetts

June 11, 1998